• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年轻女性肢端肥大症患者的心脏代谢危险因素。

Cardiometabolic risk factors in young women with macroprolactinaemia.

机构信息

Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Katowice, Poland.

Division of Pathophysiology, Department of Pathophysiology and Endocrinology, Medical University of Silesia, Zabrze, Poland.

出版信息

Endokrynol Pol. 2019;70(4):336-341. doi: 10.5603/EP.a2019.0013. Epub 2019 Mar 7.

DOI:10.5603/EP.a2019.0013
PMID:30845340
Abstract

INTRODUCTION

The predominance of high-molecular-weight forms of prolactin in plasma is referred to as macroprolactinaemia. Unlike monomeric hyperprolactinaemia, no previous study has investigated cardiometabolic risk factors in subjects with elevated macroprolactin content.

MATERIAL AND METHODS

We studied two age-, weight-, and blood pressure-matched groups of premenopausal women: 11 women with macroprolactinaemia and 11 women with prolactin levels within the reference range. The outcomes of interest included: glucose homeostasis markers, plasma lipids, as well as plasma levels of uric acid, high-sensitivity C-reactive protein (hsCRP), fibrinogen, homocysteine, and 25-hydroxyvitamin D.

RESULTS

Circulating levels of hsCRP and 2-h postchallenge plasma glucose, as well as the homeostatic model assessment 1 of insulin resistance ratio, were higher, while levels of HDL cholesterol and 25-hydroxyvitamin D were lower in women with macroprolactinaemia than in women without elevated levels of prolactin. In women with elevated levels of big-big prolactin, values of hsCRP and 25-hydroxyvitamin D correlated with the degree of insulin resistance and, similarly to HDL cholesterol and 2-h postchallenge plasma glucose, with macroprolactin content. There were no differences between the study groups in concentrations of fasting glucose, total cholesterol, LDL cholesterol, triglycerides, uric acid, fibrinogen, and homocysteine.

CONCLUSIONS

The obtained results indicate that young women with macroprolactinaemia seem to be characterised by slightly increased cardiometabolic risk.

摘要

简介

血浆中高分子量形式的催乳素占优势被称为巨泌乳素血症。与单体性高催乳素血症不同,以前没有研究调查过具有升高的大分子催乳素含量的受试者的心血管代谢危险因素。

材料和方法

我们研究了两组年龄、体重和血压匹配的绝经前妇女:11 名巨泌乳素血症患者和 11 名催乳素水平在参考范围内的妇女。感兴趣的结果包括:葡萄糖稳态标志物、血浆脂质以及尿酸、高敏 C 反应蛋白 (hsCRP)、纤维蛋白原、同型半胱氨酸和 25-羟维生素 D 的血浆水平。

结果

与催乳素水平正常的妇女相比,巨泌乳素血症妇女的 hsCRP 和 2 小时餐后血浆葡萄糖以及胰岛素抵抗评估模型 1 的比值较高,而高密度脂蛋白胆固醇和 25-羟维生素 D 的水平较低。在大-大催乳素水平升高的妇女中,hsCRP 和 25-羟维生素 D 的水平与胰岛素抵抗的程度相关,与高密度脂蛋白胆固醇和 2 小时餐后血浆葡萄糖相似,与巨催乳素含量相关。空腹血糖、总胆固醇、LDL 胆固醇、甘油三酯、尿酸、纤维蛋白原和同型半胱氨酸在两组研究对象之间无差异。

结论

研究结果表明,年轻的巨泌乳素血症妇女似乎具有略高的心血管代谢风险。

相似文献

1
Cardiometabolic risk factors in young women with macroprolactinaemia.年轻女性肢端肥大症患者的心脏代谢危险因素。
Endokrynol Pol. 2019;70(4):336-341. doi: 10.5603/EP.a2019.0013. Epub 2019 Mar 7.
2
Macroprolactinaemia modulates cardiometabolic effects of fenofibrate in men with atherogenic dyslipidaemia: A pilot study.巨泌乳素血症调节致动脉粥样硬化性血脂异常男性患者中非诺贝特的心脏代谢作用:一项初步研究。
J Clin Pharm Ther. 2020 Feb;45(1):115-121. doi: 10.1111/jcpt.13036. Epub 2019 Aug 24.
3
Cardiometabolic Risk Factors in Men with Elevated Macroprolactin Content: A Pilot Study.大泌乳素含量升高男性的心脏代谢危险因素:一项初步研究。
Exp Clin Endocrinol Diabetes. 2021 Jan;129(1):7-13. doi: 10.1055/a-0902-4439. Epub 2019 Jun 11.
4
Impact of Macroprolactinemia on Cardiometabolic Effects of Atorvastatin in Women With Hypercholesterolemia.巨泌乳素血症对女性高胆固醇血症患者阿托伐他汀的心血代谢作用的影响。
Am J Cardiol. 2019 Oct 15;124(8):1207-1212. doi: 10.1016/j.amjcard.2019.07.017. Epub 2019 Jul 23.
5
Autoimmune Thyroiditis Attenuates Cardiometabolic Effects of Cabergoline in Young Women With Hyperprolactinemia.自身免疫性甲状腺炎可减轻催乳素血症年轻女性中卡麦角林的心脏代谢作用。
J Clin Pharmacol. 2023 Aug;63(8):886-894. doi: 10.1002/jcph.2245. Epub 2023 May 8.
6
Different effects of fenofibrate on cardiometabolic risk factors in young women with and without hyperprolactinemia.非诺贝特对伴有和不伴有高泌乳素血症的年轻女性心血管代谢危险因素的不同影响。
Pharmacol Rep. 2019 Feb;71(1):61-66. doi: 10.1016/j.pharep.2018.09.004. Epub 2018 Sep 6.
7
Vitamin D Status Determines Cardiometabolic Effects of Cabergoline in Women with Elevated Prolactin Levels: A Pilot Study.维生素 D 状况决定了卡麦角林对高催乳素血症女性的心脏代谢影响:一项初步研究。
Nutrients. 2023 May 14;15(10):2303. doi: 10.3390/nu15102303.
8
Different effects of cabergoline and bromocriptine on metabolic and cardiovascular risk factors in patients with elevated prolactin levels.卡麦角林和溴隐亭对催乳素水平升高患者代谢及心血管危险因素的不同影响。
Basic Clin Pharmacol Toxicol. 2015 Mar;116(3):251-6. doi: 10.1111/bcpt.12307. Epub 2014 Sep 11.
9
Impaired Cardiometabolic Effects of Bromocriptine in Men With Early-Onset Androgenic Alopecia.早期雄激素性脱发男性中溴隐亭对代谢心脏影响受损。
J Clin Pharmacol. 2023 Mar;63(3):345-351. doi: 10.1002/jcph.2163. Epub 2022 Nov 2.
10
Different Effects of Atorvastatin on Cardiometabolic Risk Factors in Young Women With and Without Hyperprolactinemia.阿托伐他汀对伴有和不伴有高泌乳素血症的年轻女性心血管代谢危险因素的不同影响。
J Clin Pharmacol. 2019 Jan;59(1):83-89. doi: 10.1002/jcph.1301. Epub 2018 Aug 21.

引用本文的文献

1
The Effect of Metformin on Pituitary Function in Postmenopausal Women with Subclinical Hypothyroidism and Macroprolactinemia: A Single-Center Prospective Case-Control Study.二甲双胍对亚临床甲状腺功能减退和巨泌乳素血症绝经后女性垂体功能的影响:一项单中心前瞻性病例对照研究
Pharmaceuticals (Basel). 2025 Jun 2;18(6):834. doi: 10.3390/ph18060834.
2
Vitamin D Status Determines Cardiometabolic Effects of Cabergoline in Women with Elevated Prolactin Levels: A Pilot Study.维生素 D 状况决定了卡麦角林对高催乳素血症女性的心脏代谢影响:一项初步研究。
Nutrients. 2023 May 14;15(10):2303. doi: 10.3390/nu15102303.
3
The interplay between prolactin and cardiovascular disease.
催乳素与心血管疾病的相互作用。
Front Endocrinol (Lausanne). 2023 Jan 10;13:1018090. doi: 10.3389/fendo.2022.1018090. eCollection 2022.